HSA — authorised 18 December 2013
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
🇸🇬 Incruse Ellipta in Singapore
HSA authorised Incruse Ellipta on 18 December 2013
Marketing authorisation
Incruse Ellipta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Singapore
Frequently asked questions
Is Incruse Ellipta approved in Singapore?
Yes. HSA authorised it on 18 December 2013.
Who is the marketing authorisation holder for Incruse Ellipta in Singapore?
GLAXOSMITHKLINE holds the Singaporean marketing authorisation.